Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 6,686 shares at $44.50 ($301K) on 2025-01-08, disclosed to the SEC on 2025-01-10.
Scheduled sale ($301k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.34 | 2,142 | $97K | 32.3% |
| 2 | $45.34 | 2,142 | $97K | 32.3% |
| 3 | $44.50 | 2,402 | $107K | 35.5% |
| Total | $45.04 avg | 6,686 | $301K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |